AC Immune SA ACIU

$2.58 +0.39% at last close

Recent SEC Filings

FormDescriptionFiledDocument
6-K 6-K 2026-08-11 View →
6-K 6-K 2026-08-05 View →
6-K FORM 6-K 2026-06-30 View →
4 PRIMARY DOCUMENT 2026-06-15 View →
4 PRIMARY DOCUMENT 2026-06-15 View →
4 PRIMARY DOCUMENT 2026-06-15 View →
4 PRIMARY DOCUMENT 2026-06-15 View →
4 PRIMARY DOCUMENT 2026-06-15 View →
6-K FORM 6-K 2026-06-11 View →
6-K FORM 6-K 2026-06-11 View →
4 PRIMARY DOCUMENT 2026-05-18 View →
6-K FORM 6-K 2026-05-15 View →
6-K FORM 6-K 2026-05-12 View →
6-K FORM 6-K 2026-04-30 View →
6-K FORM 6-K 2026-04-30 View →
4 PRIMARY DOCUMENT 2026-04-16 View →
6-K FORM 6-K 2026-04-07 View →
6-K 6-K 2026-03-13 View →
20-F 20-F 2026-03-13 View →
6-K FORM 6-K 2026-02-24 View →
6-K FORM 6-K 2026-02-17 View →
6-K FORM 6-K 2025-12-11 View →
6-K 6-K 2025-11-04 View →
6-K FORM 6-K 2025-09-04 View →
6-K 6-K 2025-08-05 View →
6-K FORM 6-K 2025-06-20 View →
6-K FORM 6-K 2025-06-11 View →
6-K FORM 6-K 2025-05-19 View →
6-K 6-K 2025-04-30 View →
6-K FORM 6-K 2025-03-13 View →
20-F 20-F 2025-03-13 View →
6-K FORM 6-K 2024-12-18 View →
6-K FORM 6-K 2024-12-10 View →
6-K FORM 6-K 2024-11-14 View →
6-K 6-K 2024-11-05 View →
6-K FORM 6-K 2024-09-19 View →
6-K FORM 6K 2024-09-17 View →
6-K FORM 6-K 2024-08-28 View →
424B5 FORM 424B5 2024-08-06 View →
6-K FORM 6-K 2024-08-06 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$2.58
Market Cap
$255.53 million
52-Week Range
$2.00 – $4.00
Average Volume
208K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.